Treatment-Free Remission (TFR) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DMR) Discontinuing Dasatinib (DASFREE)

Authors :: Susanne Saussele
Sarah Larson
Antonio Jiménez-Velasco
Jeffrey H. Lipton
Neil P. Shah
Fabrizio Pane
Francois-Xavier Mahon
Moshe Yair Levy
Oumar Sy
Franck-Emmanuel Nicolini
María Teresa Gómez-Casares
Delphine Rea
Jose Valentín García-Gutiérrez
Patricia Martin-Regueira
Michael J. Mauro
Source :: Clinical Lymphoma Myeloma and Leukemia. 18:S220-S221
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Hematology
Chronic phase chronic myeloid leukemia
Dasatinib
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Molecular Response
medicine
In patient
business
medicine.drug

Full Text Access

Tools